Table 2.
The individual proportional changes in the release of MCP-1, IL-12p70 and the clinical inflammatory response after therapy
| Patient | MCP-1 | IL-12p7 | BOP | PD ≥5 |
|---|---|---|---|---|
| 1 | −47% | 147% | −81% | −98% |
| 2 | −27% | 81% | −92% | −85% |
| 3 | −43% | 75% | −84% | −89% |
| 4 | −67% | 314% | −92% | −79% |
| 5 | −24% | 227% | −79% | −86% |
| 6 | −41% | 97% | −86% | −70% |
| 7 | 9% | 2% | −37% | −89% |
| 8 | 32% | −4% | −74% | −47% |
BOP,bleeding on probing; PD, probing depths, recorded to the nearest millimetre.